Jørgen Vestbo

93.1k total citations · 24 hit papers
556 papers, 49.7k citations indexed

About

Jørgen Vestbo is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Jørgen Vestbo has authored 556 papers receiving a total of 49.7k indexed citations (citations by other indexed papers that have themselves been cited), including 447 papers in Pulmonary and Respiratory Medicine, 240 papers in Physiology and 51 papers in Epidemiology. Recurrent topics in Jørgen Vestbo's work include Chronic Obstructive Pulmonary Disease (COPD) Research (405 papers), Respiratory Support and Mechanisms (196 papers) and Asthma and respiratory diseases (193 papers). Jørgen Vestbo is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (405 papers), Respiratory Support and Mechanisms (196 papers) and Asthma and respiratory diseases (193 papers). Jørgen Vestbo collaborates with scholars based in United Kingdom, Denmark and United States. Jørgen Vestbo's co-authors include Peter Lange, Paul Jones, Àlvar Agustí, Bartolomé R. Celli, Eva Prescott, Peter M.A. Calverley, Fernando J. Martínez, Claus Vogelmeier, Julie Yates and Leonardo M. Fabbri and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jørgen Vestbo

534 papers receiving 48.2k citations

Hit Papers

Global Strategy for the D... 1996 2026 2006 2016 2012 2007 2010 1998 2003 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
    2012 9.4k citations Jørgen Vestbo, Àlvar Agustí et al. American Journal of Respiratory and Critical Care Medicine profile →
  2. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
    2007 2.3k citations Christine Jenkins, Paul Jones et al. profile →
  3. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
    2010 2.1k citations Jørgen Vestbo, Hana Müllerová et al. profile →
  4. A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma
    1998 935 citations Peter Lange, Jørgen Vestbo et al. profile →
  5. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    2003 894 citations Jørgen Vestbo, Paul Jones et al. profile →
  6. Characterisation of COPD heterogeneity in the ECLIPSE cohort
    2010 822 citations Àlvar Agustí, Ruth Tal‐Singer et al. profile →
  7. Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
    1999 752 citations Peter Lange, Jørgen Vestbo et al. American Journal of Respiratory and Critical Care Medicine profile →
  8. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
    2015 739 citations Peter Lange, Àlvar Agustí et al. profile →
  9. Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
    2010 726 citations Àlvar Agustí, Gerard J. Criner et al. American Journal of Respiratory and Critical Care Medicine profile →
  10. Changes in Forced Expiratory Volume in 1 Second over Time in COPD
    2011 680 citations Jørgen Vestbo, Julie Yates et al. profile →
  11. Treatable traits: toward precision medicine of chronic airway diseases
    2016 653 citations Àlvar Agustí, Elisabeth H. Bel et al. European Respiratory Journal profile →
  12. Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
    2012 620 citations Àlvar Agustí, Stephen I. Rennard et al. profile →
  13. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
    1999 594 citations Jørgen Vestbo, Peter Lange et al. profile →
  14. Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
    2016 547 citations Jørgen Vestbo, Claus Vogelmeier et al. profile →
  15. Association of Chronic Mucus Hypersecretion With FEV1 Decline and Chronic Obstructive Pulmonary Disease Morbidity. Copenhagen City Heart Study Group
    1996 547 citations Jørgen Vestbo et al. American Journal of Respiratory and Critical Care Medicine profile →
  16. Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study
    2008 541 citations Christine Jenkins, Paul Jones et al. American Journal of Respiratory and Critical Care Medicine profile →
  17. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
    2008 510 citations Jørgen Vestbo, Ruth Tal‐Singer et al. European Respiratory Journal profile →
  18. Chronic obstructive pulmonary disease
    2015 458 citations Jørgen Vestbo et al. profile →
  19. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
    2017 452 citations Gerard J. Criner, Alberto Papi et al. European Respiratory Journal profile →
  20. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
    2018 398 citations Alberto Papi, Jørgen Vestbo et al. profile →
  21. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
    2012 313 citations Julie Yates, Ruth Tal‐Singer et al. American Journal of Respiratory and Critical Care Medicine profile →
  22. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
    2016 312 citations Jørgen Vestbo, Julie Yates et al. profile →
  23. Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification: A Study of the General Population
    2012 287 citations Peter Lange, Jacob Louis Marott et al. American Journal of Respiratory and Critical Care Medicine profile →
  24. The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma
    2020 277 citations Alexander G. Mathioudakis, Jørgen Vestbo et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jørgen Vestbo 41.0k 22.6k 4.4k 3.6k 3.3k 556 49.7k
Àlvar Agustí 34.8k 0.8× 21.9k 1.0× 3.7k 0.8× 3.6k 1.0× 2.7k 0.8× 517 46.6k
Bartolomé R. Celli 36.8k 0.9× 17.5k 0.8× 3.2k 0.7× 3.6k 1.0× 2.0k 0.6× 483 42.7k
Don D. Sin 24.9k 0.6× 12.4k 0.5× 3.0k 0.7× 3.3k 0.9× 2.1k 0.6× 505 33.7k
Fernando J. Martínez 41.9k 1.0× 15.6k 0.7× 6.4k 1.5× 3.8k 1.1× 2.6k 0.8× 647 54.6k
Leonardo M. Fabbri 27.9k 0.7× 19.0k 0.8× 3.6k 0.8× 2.1k 0.6× 3.1k 0.9× 487 39.5k
Emiel F.�M. Wouters 27.1k 0.7× 14.6k 0.6× 3.4k 0.8× 3.3k 0.9× 1.6k 0.5× 705 41.5k
Paul Jones 35.7k 0.9× 17.8k 0.8× 3.0k 0.7× 2.5k 0.7× 2.3k 0.7× 343 40.4k
David M. Mannino 18.4k 0.4× 10.1k 0.4× 7.1k 1.6× 2.2k 0.6× 1.7k 0.5× 345 32.8k
Richard Beasley 17.7k 0.4× 21.9k 1.0× 2.9k 0.7× 1.1k 0.3× 2.6k 0.8× 596 34.9k
Klaus F. Rabe 25.9k 0.6× 18.2k 0.8× 2.2k 0.5× 1.9k 0.5× 2.3k 0.7× 585 37.6k

Countries citing papers authored by Jørgen Vestbo

Since Specialization
Citations

This map shows the geographic impact of Jørgen Vestbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen Vestbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen Vestbo more than expected).

Fields of papers citing papers by Jørgen Vestbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørgen Vestbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen Vestbo. The network helps show where Jørgen Vestbo may publish in the future.

Co-authorship network of co-authors of Jørgen Vestbo

This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen Vestbo. A scholar is included among the top collaborators of Jørgen Vestbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen Vestbo. Jørgen Vestbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papi, Alberto, et al.. (2024). Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY. Therapeutic Advances in Respiratory Disease. 18. 2693833540–2693833540. 3 indexed citations
2.
Çolak, Yunus, Peter Lange, Jørgen Vestbo, Børge G. Nordestgaard, & Shoaib Afzal. (2024). Susceptible Young Adults and Development of Chronic Obstructive Pulmonary Disease Later in Life. American Journal of Respiratory and Critical Care Medicine. 210(5). 607–617. 8 indexed citations
3.
Çolak, Yunus, Anders Løkke, Jacob Louis Marott, et al.. (2024). Low smoking exposure and development and prognosis of COPD over four decades: a population-based cohort study. European Respiratory Journal. 64(3). 2400314–2400314. 4 indexed citations
4.
Marott, Jacob Louis, Truls Sylvan Ingebrigtsen, Yunus Çolak, et al.. (2024). Predicting exacerbations in COPD in the Danish general population. Respiratory Medicine. 224. 107557–107557. 2 indexed citations
5.
Elbehairy, Amany F., Helen Marshall, Josephine H. Naish, et al.. (2024). Advances in COPD imaging using CT and MRI: linkage with lung physiology and clinical outcomes. European Respiratory Journal. 63(5). 2301010–2301010. 5 indexed citations
6.
Hoel, Hedda, Shoaib Afzal, Jakob Hjorth von Stemann, et al.. (2023). Elevated Levels of Interleukin-1β and Interleukin-10 Are Associated With Faster Lung Function Decline in People With Well-Treated Human Immunodeficiency Virus. The Journal of Infectious Diseases. 228(8). 1080–1088. 3 indexed citations
7.
Sivapalan, Pradeesh, Josefin Eklöf, Christian B. Laursen, et al.. (2023). Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients. Biomedicines. 11(7). 1974–1974. 3 indexed citations
8.
Vardavas, Constantine, Alexander G. Mathioudakis, Katerina Nikitara, et al.. (2022). Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe. European Respiratory Review. 31(166). 220098–220098. 55 indexed citations
9.
Sivapalan, Pradeesh, András Bikov, Charlotte Suppli Ulrik, et al.. (2021). Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial. Journal of Clinical Medicine. 10(12). 2734–2734. 2 indexed citations
10.
Mathioudakis, Alexander G., Pradeesh Sivapalan, Elizabeth Stovold, et al.. (2021). Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study. Biomedicines. 9(12). 1837–1837. 5 indexed citations
11.
Marott, Jacob Louis, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, & Peter Lange. (2021). Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis. American Journal of Respiratory and Critical Care Medicine. 204(8). 910–920. 72 indexed citations
12.
Reddel, Helen K., Jørgen Vestbo, Àlvar Agustí, et al.. (2021). Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. European Respiratory Journal. 58(3). 2003927–2003927. 44 indexed citations
13.
Marott, Jacob Louis, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, & Peter Lange. (2020). Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality. American Journal of Respiratory and Critical Care Medicine. 202(2). 210–218. 59 indexed citations
14.
Çolak, Yunus, Shoaib Afzal, Børge G. Nordestgaard, Jørgen Vestbo, & Peter Lange. (2019). Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. American Journal of Respiratory and Critical Care Medicine. 201(6). 671–680. 65 indexed citations
15.
Vestbo, Jørgen, et al.. (2016). Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 3(4). 748–757. 4 indexed citations
16.
Çolak, Yunus, Jacob Louis Marott, Jørgen Vestbo, & Peter Lange. (2014). Overweight and Obesity May Lead to Under-diagnosis of Airflow Limitation: Findings from the Copenhagen City Heart Study. COPD Journal of Chronic Obstructive Pulmonary Disease. 12(1). 5–13. 38 indexed citations
17.
Janssen, Daisy J.A., Àlvar Agustí, Hana Müllerová, et al.. (2013). The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort. European Respiratory Journal. 42(Suppl 57). 4851–4851. 1 indexed citations
18.
Agustí, Àlvar, Massimo Corradi, Géraldine Cohuet, et al.. (2013). FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations. European Respiratory Journal. 42(Suppl 57). P762–P762. 1 indexed citations
19.
Vestbo, Jørgen, et al.. (2010). Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 7(5). 331–336. 25 indexed citations
20.
Løkke, Anders, Peter Lange, Henrik Scharling, P. G. Fabricius, & Jørgen Vestbo. (2006). Developing COPD: a 25 year follow up study of the general population. Thorax. 61(11). 935–939. 432 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Àlvar Agustí Breakdown of academic impact, for papers by Bartolomé R. Celli Breakdown of academic impact, for papers by Don D. Sin Breakdown of academic impact, for papers by Fernando J. Martínez Breakdown of academic impact, for papers by Leonardo M. Fabbri Breakdown of academic impact, for papers by Emiel F.�M. Wouters Breakdown of academic impact, for papers by Paul Jones Breakdown of academic impact, for papers by David M. Mannino Breakdown of academic impact, for papers by Richard Beasley Breakdown of academic impact, for papers by Klaus F. Rabe
Rankless by CCL
2026